Skip to main content
. 2024 Oct 17;25:378. doi: 10.1186/s12931-024-02993-x

Fig. 5.

Fig. 5

Forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) assessed pre-dose at Week 3 – adjusted mean differences between treatments (intention-to-treat set). FEV1 data available from 98, 98 and 102 patients with BDP/FF/G, BDP/FF and placebo, respectively; FVC data available from 99, 99 and 105 patients, respectively. BDP, beclometasone dipropionate; FF, formoterol fumarate; G, glycopyrronium